Heterocyclic cyclopamine analogs and methods of use thereof

A kind of compound, cycloalkyl technology, applied in the field of cyclopamine analogs

Inactive Publication Date: 2010-03-31
INFINITY DISCOVERY INC
View PDF5 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although inhibitors of the hedgehog pathway have been identified, there

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Heterocyclic cyclopamine analogs and methods of use thereof
  • Heterocyclic cyclopamine analogs and methods of use thereof
  • Heterocyclic cyclopamine analogs and methods of use thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0194]

[0195] Step A

[0196]

[0197] Cyclopamine 2 (5.02 g, 12.2 mmol, 1.0 equiv) was dissolved in anhydrous pyridine (25 mL). DMAP (300 mg, 2.44 mmol, 0.2 equiv) and triethylamine (5.5 mL, 39.1 mmol, 3.2 equiv) were added, followed by BtO-Cbz (10.5 g, 39.1 mmol, 3.2 equiv) and the mixture was heated at 40 °C for 2 h . The mixture was cooled to room temperature, treated with 30 mL of water, heated to give a homogeneous solution, and cooled to room temperature. The white precipitate formed was collected by filtration, the filter cake was washed with water (3×50 mL) and air dried to give 9.53 g of crude product which was crystallized from toluene / heptane (1:9, 70 mL) to give 6.75 g of the desired product.

[0198] Step B:

[0199]

[0200]To a solution of diethylzinc (572 mg, 482 μL, 4.63 mmol, 3 equiv) in DCM (5.0 mL) was added bis(2,6-dimethylphenyl)phosphoric acid (1.42 g, 4.63 mmol) at -20 °C , 3 eq) in DCM (15 mL) while keeping the reaction temperature belo...

Embodiment 2

[0221]

[0222] A solution of compound 9 (100.0 mg, 0.17 mmol, 1.0 equiv) in ethanol (4 mL) was treated with hydrazine (16 mg, 0.34 mmol, 2.0 equiv) and heated at 70° C. for 0.5 hour. The mixture was concentrated in vacuo and purified by flash silica gel chromatography (20→60% ether / hexanes) to give the protected pyrazole (72.0 mg) as a white solid.

[0223] In a flask equipped with a stir bar and rubber septum, the product carbamate isoxazole was dissolved in EtOAc (7ml). The solution was bubbled with nitrogen and 10% Pd / C (wet, Degussa type E101, Aldrich, 25 mg) was added. The mixture was bubbled with nitrogen, then hydrogen and stirred at room temperature for 2 hours. The mixture was then bubbled with nitrogen, filtered through a 0.45 μm polyethylene membrane, and concentrated to a clear oil. The oil was purified by flash chromatography on silica gel (0.5% ammonium hydroxide / 2→10% MeOH / DCM), concentration of the pure fractions gave an oil, lyophilization from 7% water / ...

Embodiment 3

[0225]

[0226] Compound 11 was synthesized according to the method described in Example 2, using methylhydrazine instead of hydrazine. ([M+H] = 464.7 m / z).

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The present invention relates to steroidal alkaloid-like compounds that can be used in the treatment of hedgehog pathway related disorders, particularly cancer.

Description

technical field [0001] The present invention relates generally to cyclopamine analogs, pharmaceutical compositions thereof, and methods of using such analogs and compositions. These compounds and compositions are useful in the treatment of hedgehog mediated diseases such as cancer and psoriasis. Background technique [0002] Hedgehog polypeptides are secreted proteins that serve as signaling ligands of the hedgehog pathway. Three different forms of the hedgehog protein are found in humans: Sonic hedgehog (Shh), Desert hedgehog (Dhh) and Indian hedgehog (Ihh). Sonic hedgehog is the most prevalent hedgehog member and the best characterized hedgehog family ligand in mammals. Before secretion, Shh undergoes intramolecular cleavage and lipid modification reactions. This lipid-modified peptide is responsible for signaling activities. [0003] In some cancers, inhibiting the hedgehog pathway inhibits tumor growth. For example, anti-hedgehog antibodies have been shown to antago...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07D491/04C07D491/10A61K31/4747A61K31/675A61K31/4355
CPCC07D491/14C07D513/14A61P35/00A61P35/02A61P43/00C07D491/04A61K31/4355A61K31/675
Inventor A·C·卡斯特罗M·J·格罗甘M·特伦布莱
Owner INFINITY DISCOVERY INC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap